Why the study?
Does combined treatment with olmesartan plus azelnidipine reduce spontaneous infarct volume and oxidative stress in stroke-prone spontaneously hypertensive rats?
Population
Stroke-prone spontaneously hypertensive rats (SHR-SP)
Comparison
Olmesartan and azelnidipine monotherapy and… vs Vehicle group
Design
Preclinical
Authors
Loading...
Does not change clinical practice; leaves open translation of synergistic neuroprotection to human trials.
Does combined treatment with olmesartan plus azelnidipine reduce spontaneous infarct volume and oxidative stress in stroke-prone spontaneously hypertensive rats?
A low-dose combination of olmesartan and azelnidipine provides synergistic neuroprotective effects, reducing infarct volume and oxidative stress in a rat model of stroke.
Omote et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: